Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jiangsu Sihuan Bioengineering Co Ltd
Total Current Assets
Jiangsu Sihuan Bioengineering Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
|
Total Current Assets
¥396.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
0%
|
|
|
Beigene Ltd
HKEX:6160
|
Total Current Assets
¥43.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Current Assets
¥22B
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Total Current Assets
¥4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Total Current Assets
¥11.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Total Current Assets
¥2.8B
|
CAGR 3-Years
104%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jiangsu Sihuan Bioengineering Co Ltd
Glance View
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Wuxi, Jiangsu and currently employs 254 full-time employees. The Company’s main products include interleukin, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), tablets, bulk drugs, infusion glass bottles, soft bag infusion, syrup and healthcare products, among others. The firm is also engaged in landscape engineering, maintenance projects, the sale of nursery stocks and other businesses. The firm distributes its products in domestic market and to overseas markets.
See Also
What is Jiangsu Sihuan Bioengineering Co Ltd's Total Current Assets?
Total Current Assets
396.8m
CNY
Based on the financial report for Sep 30, 2025, Jiangsu Sihuan Bioengineering Co Ltd's Total Current Assets amounts to 396.8m CNY.
What is Jiangsu Sihuan Bioengineering Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
0%
Over the last year, the Total Current Assets growth was -22%. The average annual Total Current Assets growth rates for Jiangsu Sihuan Bioengineering Co Ltd have been -12% over the past three years , -10% over the past five years .
